INGN 241

AXP000153.1 · Viral vector gene therapy

Platform
adenovirus (Ad5, non-replicating, mda-7/IL-24)
Targets
IL24
Originator
Introgen Therapeutics
Sponsor
Introgen Therapeutics

Names

NameTypeSource
INGN 241preferred name, codecurator, ncit
Ad-MDA-7 ambiguouscodencit
Adenovector Encoding MDA7 ambiguoussynonymncit

Virus

Role
In vivo gene transfer
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5
Replication
non replicating
Modifications
non-replicating adenoviral vector encoding human IL-24 (mda-7)
Transgenes
IL24
Route
intratumoral
Source
evidence

Cross-references

NCI Thesaurus
C48368

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT00116363Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit MelanomaUnknownPhase 22005-0325Malignant Melanoma; Neoplasm Metastasis

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 35149587Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis.Cancer research2022cited by trial NCT00116363
PMID 15585416Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.Molecular therapy : the journal of the American Society of Gene Therapy2005name in title: INGN 241
PMID 15585417Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.Molecular therapy : the journal of the American Society of Gene Therapy2005name in title: INGN 241

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 29551126Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.Advances in cancer research2018name in abstract: INGN 241
PMID 23481022Stabilization of MDA-7/IL-24 for colon cancer therapy.Cancer letters2013name in abstract: INGN 241
PMID 23661648Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.Molecular pharmacology2013name in abstract: INGN 241
PMID 20613485MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.Anti-cancer drugs2010name in abstract: INGN 241
PMID 20732354The development of MDA-7/IL-24 as a cancer therapeutic.Pharmacology & therapeutics2010name in abstract: INGN 241
PMID 19276652Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.Cancer biology & therapy2009name in abstract: INGN 241
PMID 18774929Ad-MDA-7; INGN 241: a review of preclinical and clinical experience.Expert opinion on biological therapy2008name in title: INGN 241
PMID 17208263Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.Toxicology and applied pharmacology2007name in abstract: INGN 241
PMID 17477796Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?Expert opinion on biological therapy2007name in abstract: INGN 241
PMID 15880678MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?Journal of cellular biochemistry2005name in abstract: INGN 241
PMID 12690708Gateways to clinical trials.Methods and findings in experimental and clinical pharmacology2003name in abstract: INGN 241
PMID 12528316INGN-241. Introgen.Current opinion in investigational drugs (London, England : 2000)2002name in title: INGN 241
Unconfirmed matches (5)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 20939432Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors.Oncology research2010name in title: Ad-MDA-7
PMID 18059175Development of Ad-mda7/IL-24-resistant lung cancer cell lines.Cancer biology & therapy2008name in title: Ad-MDA-7
PMID 16924242Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells.Oncogene2007name in title: Ad-MDA-7
PMID 17111370Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy.Journal of cellular physiology2007name in title: Ad-MDA-7
PMID 15580305Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.Oncogene2005name in title: Ad-MDA-7

NIH grants

ProjectTitleOrganisationPIYearsLinked by
R03CA140024Ultrasound-guided gene delivery in pancreatic cancerMARSHALL UNIVERSITYCLAUDIO, PIER PAOLO2009–2010name in abstract: INGN 241
P01CA104177Translational Applications of mda-7/IL-24 in CancerVIRGINIA COMMONWEALTH UNIVERSITYFISHER, PAUL B2005–2009name in abstract: INGN 241

Notes

Ad-mda7: adenovirus carrying melanoma differentiation-associated gene 7 (IL-24), injected intratumorally in phase 1 trials in melanoma and other solid tumours. Development stopped with Introgen.

How to cite

INGN 241 (AXP000153.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000153.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.